However, when NSCLC cells were treated with cisplatin, a chemotherapy drug inducing the reactive oxygen species (ROS) accumulation, YTHDF1 was decreased and led to cisplatin resistance in tumor cells via regulating the Keap1-Nrf2-AKR1C1 axis [56]. This evidence concerns the gene YTHDF1 and neoplasm.